Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H3Cl3 |
| Molecular Weight | 133.404 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(Cl)(Cl)Cl
InChI
InChIKey=UOCLXMDMGBRAIB-UHFFFAOYSA-N
InChI=1S/C2H3Cl3/c1-2(3,4)5/h1H3
| Molecular Formula | C2H3Cl3 |
| Molecular Weight | 133.404 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
1,1,1-trichloroethane (methyl chloroform) is a colorless liquid or vapour with a sharp sweet smell. It dissolves in water and other chemicals and easily evaporates into the air. TCE is non-flammable. Trichloroethane is used as a solvent and degreasing agent in industry. It is an ingredient in consumer products such as household cleaners, glues, and aerosol sprays. Methyl chloroform is also used as a chemical intermediate in the production of vinylidene chloride. It was formerly used as a food and grain fumigant. Excessive absorption of this substance through the lungs or gastrointestinal tract produces central nervous system (CNS) depression proportional to the amount absorbed. Mild liver and kidney dysfunction may occur transiently following recovery from CNS depression. The consumption of trichloroethane has been banned by the 1987 Montreal Protocol because of its ozone-depleting potential.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
735 ppm multiple, respiratory Studied dose Dose: 735 ppm Route: respiratory Route: multiple Dose: 735 ppm Sources: |
healthy, 16 years |
Other AEs: Death... |
17718 ppm multiple, respiratory Studied dose Dose: 17718 ppm Route: respiratory Route: multiple Dose: 17718 ppm Sources: |
healthy, 27 years |
Other AEs: Hepatitis... |
1380 ppm 1 times / day single, respiratory Studied dose Dose: 1380 ppm, 1 times / day Route: respiratory Route: single Dose: 1380 ppm, 1 times / day Sources: |
healthy, 30 to 60 years Health Status: healthy Age Group: 30 to 60 years Sex: M Sources: |
Other AEs: Anesthesia... |
1 % 1 times / day single, topical Studied dose Dose: 1 %, 1 times / day Route: topical Route: single Dose: 1 %, 1 times / day Sources: |
healthy, 30 years |
Other AEs: Contact dermatitis... |
90 % multiple, topical Studied dose |
healthy, 31 years |
Other AEs: Paresthesia distal... |
1 oz 1 times / day single, oral Studied dose Dose: 1 oz, 1 times / day Route: oral Route: single Dose: 1 oz, 1 times / day Sources: |
healthy, 47 years |
Other AEs: Nausea, Vomiting... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Death | 735 ppm multiple, respiratory Studied dose Dose: 735 ppm Route: respiratory Route: multiple Dose: 735 ppm Sources: |
healthy, 16 years |
|
| Hepatitis | 17718 ppm multiple, respiratory Studied dose Dose: 17718 ppm Route: respiratory Route: multiple Dose: 17718 ppm Sources: |
healthy, 27 years |
|
| Anesthesia | 1380 ppm 1 times / day single, respiratory Studied dose Dose: 1380 ppm, 1 times / day Route: respiratory Route: single Dose: 1380 ppm, 1 times / day Sources: |
healthy, 30 to 60 years Health Status: healthy Age Group: 30 to 60 years Sex: M Sources: |
|
| Contact dermatitis | 1 % 1 times / day single, topical Studied dose Dose: 1 %, 1 times / day Route: topical Route: single Dose: 1 %, 1 times / day Sources: |
healthy, 30 years |
|
| Paresthesia distal | 90 % multiple, topical Studied dose |
healthy, 31 years |
|
| Diarrhea | 1 oz 1 times / day single, oral Studied dose Dose: 1 oz, 1 times / day Route: oral Route: single Dose: 1 oz, 1 times / day Sources: |
healthy, 47 years |
|
| Nausea | 1 oz 1 times / day single, oral Studied dose Dose: 1 oz, 1 times / day Route: oral Route: single Dose: 1 oz, 1 times / day Sources: |
healthy, 47 years |
|
| Vomiting | 1 oz 1 times / day single, oral Studied dose Dose: 1 oz, 1 times / day Route: oral Route: single Dose: 1 oz, 1 times / day Sources: |
healthy, 47 years |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 27.0 |
likely |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 28.0 |
yes | |||
Page: 28.0 |
yes | |||
Page: 28.0 |
yes | |||
Page: 28.0 |
yes |
PubMed
| Title | Date | PubMed |
|---|---|---|
| 1,1,1-trichloroethane marine risk assessment with special reference to the OSPARCOM region: North Sea. | 2004-10 |
|
| Batch-test study on the dechlorination of 1,1,1-trichloroethane in contaminated aquifer material by zero-valent iron. | 2004-10 |
|
| Neurologic abnormalities in workers of a 1-bromopropane factory. | 2004-09 |
|
| Chlorinated hydrocarbon solvents. | 2004-08 |
|
| Biologic markers of exposure to chlorinated solvents. | 2004-08 |
|
| Trichloroethylene and cardiac malformations. | 2004-08 |
|
| Acute effects of 1,1,1-trichloroethane on human olfactory functioning. | 2004-05-22 |
|
| Intravenous self-administration of abused solvents and anesthetics in mice. | 2004-02-06 |
|
| Photolysis of chloral under atmospheric conditions. | 2004-02-01 |
|
| Rapid and sensitive static headspace gas chromatography-mass spectrometry method for the analysis of ethanol and abused inhalants in blood. | 2004-01-25 |
|
| Synthesis and protection of aryl sulfates using the 2,2,2-trichloroethyl moiety. | 2004-01-22 |
|
| Pi-halogen dimer interactions and the inclusion chemistry of a new tetrahalo aryl host. | 2004-01-21 |
|
| Changes in the regional emissions of greenhouse gases and ozone-depleting compounds. | 2004-01-15 |
|
| Reduction of halogenated ethanes by green rust. | 2004-01 |
|
| Ambient, indoor and personal exposure relationships of volatile organic compounds in Mexico City Metropolitan Area. | 2004 |
|
| Personal, indoor, and outdoor VOC exposures in a probability sample of children. | 2004 |
|
| Investigation of the inhibitory effect of silica on the degradation of 1,1,1-trichloroethane by granular iron. | 2003-12-15 |
|
| The effect of multicomponent diffusion on NAPL dissolution from spherical ternary mixtures. | 2003-12 |
|
| Comparative study of the effects of toluene, benzene, 1,1,1-trichloroethane, diethyl ether, and flurothyl on anxiety and nociception in mice. | 2003-11-15 |
|
| VOC removal from contaminated groundwater through membrane pervaporation. (II): 1,1,1-trichloroethane-SDS surfactant solution system. | 2003-11 |
|
| Adsorption of volatile organic compounds by pecan shell- and almond shell-based granular activated carbons. | 2003-11 |
|
| Linear free-energy relationship analysis of the fate of chlorinated 1- and 2-carbon compounds by redox-manipulated smectite clay minerals. | 2003-10 |
|
| Six interaction profiles for simple mixtures. | 2003-10 |
|
| Dissolution of entrapped DNAPLs in variable aperture fractures: experimental data and empirical model. | 2003-09-15 |
|
| Biofiltration of 1,1,1-trichloroethane by a trickle-bed air biofilter. | 2003-09 |
|
| Sorption of volatile organic compounds on typical carpet fibers. | 2003-08 |
|
| Environmental risk assessment of airborne trichloroacetic acid--a contribution to the discussion on the significance of anthropogenic and natural sources. | 2003-07 |
|
| Input of trichloroacetic acid into the vegetation of various climate zones--measurements on several continents. | 2003-07 |
|
| Fluxes of trichloroacetic acid between atmosphere, biota, soil, and groundwater. | 2003-07 |
|
| Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. | 2003-06-15 |
|
| Evaluation of toluene dependence and cross-sensitization to diazepam. | 2003-05-16 |
|
| Inhaled drugs of abuse enhance serotonin-3 receptor function. | 2003-05-01 |
|
| Dehydrochlorination of 1,1,1-trichloroethane and pentachloroethane by microbially reduced ferruginous smectite. | 2003-05 |
|
| Biodegradation of chlorinated solvents in a water unsaturated topsoil. | 2003-04 |
|
| Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-D-aspartic acid in mice. | 2003-03-18 |
|
| An evaluation of Fourier transform infrared (FTIR) spectroscopy for detecting organic solvents in expired breath. | 2003-03 |
|
| Fast estimation of hydrogen-bonding donor and acceptor propensities: a GMIPp study. | 2003-02-27 |
|
| Evaluation of bacterial aerotaxis for its potential use in detecting the toxicity of chemicals to microorganisms. | 2003-02-27 |
|
| VOC exposures in a mixed-use university art building. | 2003-02-07 |
|
| Development of a new respirator for organic vapors with a breakthrough detector using a semiconductor gas sensor. | 2003-02 |
|
| Stable hydrogen, carbon and chlorine isotope measurements of selected chlorinated organic solvents. | 2003-02 |
|
| Continuing emissions of methyl chloroform from Europe. | 2003-01-09 |
|
| Trichloroacetic acid in Norway spruce/soil-system. I. Biodegradation in soil. | 2003-01 |
|
| [1,1, 1-trichloroethane-induced chronic active hepatitis]. | 2003-01 |
|
| The annual course of TCA formation in the lower troposphere: a modeling study. | 2003 |
|
| Kinetics of 1,1,1-trichloroethane transformation by iron sulfide and a methanogenic consortium. | 2002-11-01 |
|
| Microbial dehalorespiration with 1,1,1-trichloroethane. | 2002-11-01 |
|
| [Method for determining chlorinated solvent residues in dry cleaning fabrics with gas chromatography-mass spectrometry]. | 2002-11 |
|
| Comparison of anaerobic dechlorinating enrichment cultures maintained on tetrachloroethene, trichloroethene, cis-dichloroethene and vinyl chloride. | 2002-10 |
|
| Tolerance to various toxicants by marine bacteria highly resistant to mercury. | 2001-10-24 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:31 GMT 2025
by
admin
on
Mon Mar 31 17:34:31 GMT 2025
|
| Record UNII |
113C650IR1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 216.24
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
||
|
IARC | 1,1,1-Trichloroethane | ||
|
CFR |
21 CFR 310.502
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
||
|
EPA PESTICIDE CODE |
81201
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C75637
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
1,1,1-TRICHLOROETHANE
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
157
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
SUB34322
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
36015
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
CHEMBL16080
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
113C650IR1
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
methylchloroform
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
200-756-3
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
1601226
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
113C650IR1
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
DTXSID0021381
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
71-55-6
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
m11071
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
6278
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
9367
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
C024566
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY | |||
|
100000127975
Created by
admin on Mon Mar 31 17:34:31 GMT 2025 , Edited by admin on Mon Mar 31 17:34:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |